Milestone Scientific (MLSS) EBIT Margin (2010 - 2026)

Milestone Scientific has disclosed EBIT Margin across 17 years of filings, most recently posting 38.3% for Q1 2026.

• In Q1 2026, EBIT Margin rose 5119.0% year-over-year to 38.3%; the TTM figure through Mar 2026 stood at 51.05% (up 3408.0% YoY), while the FY2025 annual figure was 63.52%, up 1528.0% from the prior year.
• EBIT Margin came in at 38.3% for Q1 2026 at Milestone Scientific, up from 52.63% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 38.3% in Q1 2026 to a low of 175.01% in Q2 2022.
• Average EBIT Margin over 5 years is 78.54%, with a median of 73.17% recorded in 2023.
• Year-over-year, EBIT Margin sank 5659 bps in 2022 and soared 9675 bps in 2023.
• Over 5 years, EBIT Margin stood at 89.9% in 2022, then gained by 3 bps to 87.57% in 2023, then declined by 18 bps to 103.57% in 2024, then surged by 49 bps to 52.63% in 2025, then climbed by 27 bps to 38.3% in 2026.
• Per Business Quant data, the three most recent EBIT Margin figures were 38.3% in Q1 2026, 52.63% in Q4 2025, and 48.07% in Q3 2025.